Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells

Circulation

Volumn 118, Issue 5, 2008, Pages 498-506

  Narazaki, Genta ^a   Uosaki, Hideki ^a   Teranishi, Mizue ^a   Okita, Keisuke ^a,b   Kim, Bongju ^c   Matsuoka, Satoshi ^c   Yamanaka, Shinya ^a,b,d,e   Yamashita, Jun K ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Differentiation; Endothelium; Myocardium; Stem cells

Indexed keywords

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HEART MUSCLE; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; ANIMAL; ARTERY; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; HEART MUSCLE CELL; LYMPHATIC SYSTEM; METABOLISM; METHODOLOGY; ONCOGENE MYC; PHYSIOLOGY; TRANSGENE; VEIN;

MESSENGER RNA; PLASMA PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMALS; ARTERIES; BLOOD PROTEINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; ENDOTHELIAL CELLS; GENES, MYC; LYMPHATIC SYSTEM; MESODERM; MICE; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; RNA, MESSENGER; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VEINS;

EID: 49649120250     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.769562     Document Type: Article

References (39)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
3. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-1920.
4. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408: 92-96.
5. Yamashita JK, Takano M, Hiraoka-Kanie M, Shimazu C, Peishi Y, Yanagi K, Nakano A, Inoue E, Kita F, Nishikawa SI. Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. FASEB J. 2005;19:1534-1536.
6. Yamashita J. Cardiovascular cell differentiation from ES cells. In: Mori H, Matsuda H, eds. Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches. Tokyo, Japan: Springer-Verlag GmbH; 2004: 67-80.
7. Yamaguchi T, Dumont D, Conlon R, Breitman M, Rossant J. Flk-1, an fit-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development. 1993;118:489-498.
8. Kataoka H, Takakura N, Nishikawa S, Tsuchida K, Kodama H, Kunisada T, Risau W, Kita T, Nishikawa SI. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev Growth Differ. 1997;39: 729-740.
9. + cells at a diverging point of endothelial and hemopoietic lineages. Development. 1998;125:1747-1757.
10. Yamashita JK. Differentiation and diversification of vascular cells from embryonic stem cells. Int J Hematol. 2004;80:1-6.
11. Yurugi-Kobayashi T, Itoh H, Schroeder T, Nakano A, Narazaki G, Kita F, Yanagi K, Hiraoka-Kanie M, Inoue E, Ara T, Nagasawa T, Just U, Nakao K, Nishikawa SI, Yamashita JK. Adrenomedullin/cyclic AMP pathway induces notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler Thromb Vasc Biol. 2006;26:1977-1984.
12. Kono T, Kubo H, Shimazu C, Ueda Y, Takahashi M, Yanagi K, Fujita N, Tsuruo T, Wada H, Yamashita JK. Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arterioscler Thromb Vasc Biol. 2006;26:2070-2076.
13. Yamashita JK. Differentiation of arterial, venous, and lymphatic endothelial cells from vascular progenitors. Trends Cardiovasc Med. 2007;17: 59-63.
14. Matsuyoshi N, Toda K, Horiguchi Y, Tanaka T, Nakagawa S, Takeichi M, Imamura S. In vivo evidence of the critical role of cadherin-5 in murine vascular integrity. Proc Assoc Am Physicians. 1997;109:362-371.
15. Kodama H, Nose M, Niida S, Nishikawa S, Nishikawa S. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol. 1994;22:979-984.
16. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313-317.
17. Hattori F, Chen H, Li W, Yuasa S, Onitsuka T, Shimoji K, Sasaki E, Ogawa S, Oikawa T, Fukuda K. Mitochondrial membrane potential measurement dye is applicable for the purification of mouse and marmoset embryonic stem cell-derived cardiomyocytes. Circ J. 2007;71(suppl I): 465.
18. Scaduto RC, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J. 1999;76: 469-477.
19. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113:631-642.
20. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372-376.
21. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379-391.
22. Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, Fehling HJ, Keller G. Development of definitive endoderm from embryonic stem cells in culture. Development. 2004;131:1651-1662.
23. Laugwitz KL, Moretti A, Caron L, Nakano A, Chien KR. Islet1 cardiovascular progenitors: a single source for heart lineages? Development. 2008;135:193-205.
24. Lints T, Parsons L, Hartley L, Lyons I, Harvey R. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development. 1993;119:419-431.
25. Komuro I, Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A. 1993;90:8145-8149.
26. Villa N, Walker L, Lindsell C, Gasson J, Iruela-Arispe M, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev. 2001;108:161-164.
27. Seki T, Yun J, Oh S. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res. 2003;93:682-689.
28. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J. Dosage-sensitive requirement for mouse D114 in artery development. Genes Dev. 2004;18:2474-2478.
29. Mukouyama Y, Shin D, Britsch S, Taniguchi M, Anderson D. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell. 2002;109:693-705.
30. Yuan L, Moyon D, Paidanaud L, Bréant C, Karkkainen MJ, Alitalo K, Eichmann A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development. 2002;129:4797-4806.
31. You L, Lin F, Lee C, DeMayo F, Tsai M, Tsai S. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature. 2005;435:98-104.
32. Wang H, Chen Z, Anderson D. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998;93:741-753.
33. Jain R, Padera T. Development: lymphatics make the break. Science. 2003;99:209-210.
34. Wigle J, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn M, Jackson D, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21:1505-1513.
35. Yanagi K, Takano M, Narazaki G, Uosaki H, Hoshino T, Ishii T, Misaki T, Yamashita JK. Hyperpolarization-activated cyclic nucleotide-galed channels and T-type calcium channels confer automaticity of embryonic stem cell-derived cantiomyocytes. Stem Cells. 2007;25:2712-2719.
36. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26:101-106.
37. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. In press.
38. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashila K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S, Nakao K. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol. 2007;27:2127-2134.
39. Yamahara K, Sone M, Itoh H, Yamashita JK, Yurugi-Kobayashi T, Homma K, Chao TH, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Nakao K. Augmentation of neovascularization in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One. 2008;3:e1666.